Paxman ABPXMBF 79 Receivables Turnover is 1.41 as of Mar. 2026. GuruFocus rates PXMBF with a GF Score™ of 79/100 and a GF Value™ of $4.48. The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Paxman AB ranks worse than 51.91% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Paxman AB's Revenue for the
three
months ended in Mar. 2026 was $9.61 Mil. Paxman AB's average Accounts Receivable for the
three
months ended in Mar. 2026 was $6.80 Mil.
Hence, Paxman AB's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.41.
Paxman AB (OTCPK:PXMBF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Paxman AB Receivables Turnover Related Terms
Paxman AB Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Paxman AB's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PXMBF vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Paxman AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Paxman AB's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paxman AB (PXMBF) has a Receivables Turnover of 1.41 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Paxman AB and its competitors. According to the industry distribution chart, Paxman AB ranks #421 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 51.9%.
Is Paxman AB's Receivables Turnover too high?
Paxman AB's current Receivables Turnover is 1.41. The Medical Devices & Instruments industry median Receivables Turnover is 5.55. Paxman AB's value of 1.41 is 74.6% below this industry median. Based on the distribution chart, Paxman AB ranks #421 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Paxman AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #421 out of 811 companies for Receivables Turnover. This places Paxman AB in the lower half of its industry. The industry median Receivables Turnover is 5.55. Paxman AB's value of 1.41 is 74.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.55, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paxman AB's current Receivables Turnover of 1.41 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Paxman AB and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current Receivables Turnover is 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Receivables Turnover of 1.41. The stock's GF Value™ is $4.48, compared to a current price of $3.50 — trading 21.9% below its estimated fair value. The current Receivables Turnover is 1.41 and 74.6% below the Medical Devices & Instruments industry median of 5.55. Paxman AB's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Receivables Turnover is 1.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 21.9% below its estimated GF Value™ of $4.48.
Key valuation signals for PXMBF:
Receivables Turnover: 1.41
GF Value™: $4.48 vs. price of $3.50 (21.9% below fair value)
Industry Position: 74.6% below the Medical Devices & Instruments median (#421 of 811)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
79GF Score
Get the complete analysis for PXMBF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
